SureTrader Stock Hero Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

MannKind Corp. (MNKD)

Add MNKD Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator TREND1, conix, MadHatter326, frosr6, KingDMC, $Pistol Pete$
Search This Board:
Last Post: 5/26/2015 8:20:48 PM - Followers: 306 - Board type: Free - Posts Today: 22

Welcome to MannKind Board!!!

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients.

AFREZZA® (pronounced uh-FREZZ-uh) is a rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes. AFREZZA was approved by the FDA in 2014. MannKind has a global licensing agreement with Sanofi for the development and commercialization of AFREZZA. Sanofi is responsible for global commercial, regulatory and development activities and. MannKind manufactures AFREZZA at its manufacturing facility in Danbury, CT.

AFREZZA utilizes our proprietary Technosphere® formulation technology , which is based on a class of organic molecules that are designed to self-assemble into small particles onto which drug molecules can be loaded.  We believe Technosphere represents a versatile drug delivery platform that may allow pulmonary administration of certain drugs that currently require administration by injection, such as GLP-1. Pulmonary administration provides convenience for the patient and we believe a major advantage of drugs inhaled as Technosphere formulations is that they have been shown to be absorbed very rapidly into the arterial circulation, essentially mimicking intra-arterial administration. MannKind is also developing other inhalation technologies, including an innovative line of patient-focused, breath-activated, dry powder inhalers and inhalation profiling to characterize patient inhalation.

- See more at:


Board of Directors

Alfred E. Mann

Alfred E. Mann has been one of our directors since April 1999, our Chairman of the Board since December 2001 and our Executive Chairman since January 2015. He also served as our Chief Executive Officer from October 2003 until January 2015.  Mr. Mann has founded and largely funded 14 companies in his career.  Nine were acquired at an overall total of almost $8 billion, and three companies became public.  In addition to MannKind, he is currently involved with:

• Bioness, which develops and manufactures systems to address neural deficits and to restore controlled function of paralyzed limbs;
• Second Sight, which is developing a visual prosthesis to restore sight to the blind; 
• IncuMed, which is developing novel percutaneous seals for various applications; 
• PerQFlo, which is developing drug delivery systems; and
• RoundTrip, which is developing location and identification technology.

In 1993, Mr. Mann founded and served as Chairman and Chief Executive Officer of MiniMed Inc. until August 2001 when it was acquired by Medtronic, Inc.  Medtronic MiniMed develops, manufactures and distributes microinfusion systems and continuous glucose monitoring systems that have revolutionized the treatment of Type 1 diabetes.  Mr. Mann founded and funded Medical Research Group (MRG), a developer of an artificial pancreas.  MRG was also acquired by Medtronic in 2001.  Mr. Mann also founded and served as the Chairman of the Board and Chief Executive Officer of Advanced Bionics Corporation from its founding in 1993 until it was acquired by Boston Scientific Corporation in 2004.  Advanced Bionics developed neurostimulation devices for various neural deficits, including cochlear stimulators.  Previously, Mr. Mann founded and was Chairman of the Board and CEO of Pacesetter Systems, Inc., which developed, manufactured and distributed cardiac pacemakers, from 1972 until 1985 when it was acquired by Siemens, AG.  From 1985 to September 1992, Mr. Mann continued to serve as Chairman and CEO of the successor company, Siemens-Pacesetter, Inc., Pacesetter is now the Cardiac Rhythm Management unit of St. Jude Medical.  Prior to 1972, he was President of Spectrolab, an electro-optical and aerospace systems company, and Heliotek, a semiconductor and electro-optical components manufacturer.  Mr. Mann founded these companies in 1956 and 1960, respectively, sold them to Textron Inc. in 1960 and continued to lead them until 1972, when he left for Pacesetter.  They are now part of the Boeing Company.
Mr. Mann founded and endowed, and from 1985 until 2006 served as Chairman of the Board of Trustees of The Alfred Mann Foundation, a nonprofit research organization devoted to development of advanced medical products in a variety of fields.  Mr. Mann is currently Chairman of the Board of Trustees of the Alfred Mann Institutes at the University of Southern California, Purdue University, and The Technion Institute (Israel), all of these medical research foundations founded and endowed principally by Mr. Mann.  He also serves as a Trustee for the University of Southern California, as a member of the Board of Overseers of the Keck USC School of Medicine, and as the Chairman of the Southern California Biomedical Council, a nonprofit association dedicated to the fostering of the bio-medical industry in the Los Angeles Metropolitan area.  Alfred Mann also serves as a Director of the Nevada Cancer Institute.
Mr. Mann holds B.A. and M.S. degrees in physics from the University of California, Los Angeles and honorary doctorate degrees from the University of Southern California, The Johns Hopkins University, Western University and the Technion Institute (Israel).  Mr. Mann is also a member of the National Academy of Engineering.

Ronald Consiglio


Ronald J. Consiglio has been one of our directors since October 2003. Since 1999, Mr. Consiglio has been the managing director of Synergy Trading, a securities-trading partnership. From 1999 to 2001, Mr. Consiglio was Executive Vice President and Chief Financial Officer of Trading Edge, Inc., a national automated bond-trading firm. From January 1993 to 1998 Mr. Consiglio served as Chief Executive Officer of Angeles Mortgage Investment Trust, a publicly traded Real Estate Investment Trust. His prior experience includes serving as Senior Vice President and Chief Financial Officer of Cantor Fitzgerald & Co. and as a member of its board of directors. Mr. Consiglio has served as a member of the board of trustees for the Metropolitan West Funds since 2003. Mr. Consiglio is a certified public accountant and holds a bachelor’s degree in accounting from California State University at Northridge  A good forum for discussion on Mankind

MannKind Corporation, a development stage company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diabetes and cancer. Its lead investigational product candidate, the Technosphere Insulin System, is in phase III clinical trials in the United States, Europe, and Latin America for the treatment of diabetes. This dry powder therapy consists of Technosphere particles onto which insulin molecules are loaded. These loaded particles are then aerosolized and inhaled into the deep lung using its proprietary MedTone inhaler. The company is also developing therapies for the treatment of solid tumor cancers. The lead product candidate in this program, MKC1106-PP, which is in phase I clinical trial is intended for the treatment of various solid-tumor cancers, including ovarian, colorectal, pancreatic, renal, breast, and prostate carcinomas and melanoma. MannKind was founded in 1991 and is headquartered in Valencia, CA.;;



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
Option Chain for MNKD
MNKD News: Statement of Changes in Beneficial Ownership (4) 06:03 PM
MNKD News: Could Incoming Threats Sink MannKind Corporation? 05/23/2015 10:04:02 AM
MNKD News: James S. Shannon Rejoins MannKind's Board of Directors 05/21/2015 10:30:00 AM
MNKD News: MannKind, Front and Center: The Best Product Doesn’t Always Equal the Best Stock 05/21/2015 08:59:02 AM
MNKD News: Forget MannKind Stock's Price: Here's What You Need to Focus on Instead 05/19/2015 11:36:02 AM
News News Alert: Statement of Changes in Beneficial Ownership (4) 05/26/2015 06:03:27 PM
#11575  Sticky Note *****PAIN THE NEW 10 BILLION DOLLAR DRUG ..... TREND1 05/25/15 10:12:22 PM
#11414  Sticky Note SHORT INTEREST--100.9 Million Shares conix 05/20/15 10:11:47 AM
#11191  Sticky Note Came across this tonight. Read this slide Phaeton 05/16/15 12:27:38 AM
#10033  Sticky Note $MNKD ~ MannKind Corp. due diligence report $Pistol Pete$ 04/15/15 11:54:16 PM
#8377  Sticky Note Not Looking Good For MNKD! MadHatter326 02/13/15 02:37:35 PM
#11604   Thanks Hypi for the info on MNKD.GLTY redfalcon2 05/26/15 08:20:48 PM
#11603   Good. Our time is coming. KingDMC 05/26/15 06:57:15 PM
#11602   Nice! eom. Denise Chanterelle 05/26/15 06:52:44 PM
#11601   Feeling more confident in my MNKD investment with lakingsphan0427 05/26/15 06:36:15 PM
#11600   Insiders buying and let the squeeze commence. Adam Hypi 05/26/15 06:15:29 PM
#11599   And apparently, so do others...check this out: Denise Chanterelle 05/26/15 05:53:35 PM
#11598   Correct. Diabetics love Afrezza! eom Denise Chanterelle 05/26/15 05:15:59 PM
#11597   Uncle Sam is going to love you.. lol lakingsphan0427 05/26/15 04:18:07 PM
#11596   Its a great platform and a solid stock, Hypi 05/26/15 04:10:39 PM
#11595   Re MNKD Tweet, JLS 05/26/15 04:06:48 PM
#11594   Climbing nicely into close. eom Denise Chanterelle 05/26/15 03:31:09 PM
#11593   Thanks for posting it..This tweet from Afrezza Spiro lakingsphan0427 05/26/15 02:49:59 PM
#11592 biginvestors 05/26/15 02:22:35 PM
#11591   This is just the beginning. Going long and conix 05/26/15 01:33:17 PM
#11590   Well, why not? Just added more. Aloha. eom Denise Chanterelle 05/26/15 01:05:13 PM
#11589   As well as mine. Go MNKD. eom Denise Chanterelle 05/26/15 12:35:21 PM
#11588   No wonder we are green the shorts are lakingsphan0427 05/26/15 11:28:43 AM
#11587   My only green position today!! KingDMC 05/26/15 10:58:21 AM
#11586   WOW I'm in love.. kugel 05/26/15 10:54:15 AM
#11585   Go mnkd, looking good today harry crumb 05/26/15 10:50:23 AM
#11584   There really are more "potential" positive surprises than conix 05/26/15 10:40:43 AM
#11583   Yup nothing but a bet still long MNKD. redfalcon2 05/26/15 09:28:50 AM
#11582   To be fair, Trend has posted several times yosemite47 05/25/15 11:02:59 PM
#11581   Shoot... Watching reruns of Hee Haw would be better martind18 05/25/15 10:59:50 PM
#11580   GO MNKD TREND1 05/25/15 10:55:28 PM
#11579   GO MNKD TREND1 05/25/15 10:53:03 PM
#11578   Oh Oh I Know Anguspunch 05/25/15 10:41:05 PM
#11577   Let the PAIN end now... TREND1 05/25/15 10:39:14 PM
#11576   Any positive news. Anguspunch 05/25/15 10:34:42 PM
#11575   *****PAIN THE NEW 10 BILLION DOLLAR DRUG ..... TREND1 05/25/15 10:12:22 PM
#11574   Thank God for fud you made me see kugel 05/25/15 10:01:59 PM
#11573   Yep that is amazing that folks with no Phaeton 05/25/15 09:42:55 PM
#11572   2pm r of the greatest reasons to stay martind18 05/25/15 09:29:59 PM
#11571   No worries either way but it should be Anguspunch 05/25/15 08:37:31 PM
#11570   Hope MNKD works out for you. TREND1 05/25/15 06:09:34 PM
#11568   No trades. Just buys Anguspunch 05/25/15 05:58:33 PM
#11567   SORRY you are still confused. TREND1 05/25/15 05:29:25 PM
#11566   NONE SHORT = 43% TREND1 05/25/15 05:27:15 PM
#11565   Nope! Still confused. Anguspunch 05/25/15 05:26:40 PM
#11564   Yeah, pretty chart. Lots of stuff on it. Anguspunch 05/25/15 05:22:41 PM
#11563   MNKD D BUY by TREND1 TREND1 05/25/15 04:43:57 PM
#11562   Trend in my exhaustive review of all the Phaeton 05/25/15 04:23:09 PM
#11560   Anguspunch I agree with you 100% Somebody is getting Phaeton 05/25/15 04:00:55 PM
#11557   Since 2013 one can get an auto pump TREND1 05/25/15 01:10:25 PM
#11556   Does your wife have a pump from this TREND1 05/25/15 01:05:47 PM
#11555   Here is sell on weekly TREND1 05/25/15 12:58:16 PM
#11554   HERE IS BUY ON DAILY DATED MAY 13 TREND1 05/25/15 12:56:37 PM
#11553   Yeah, Al just might! eom Denise Chanterelle 05/25/15 12:54:15 PM
#11552   Excellent post! Aloha. eom Denise Chanterelle 05/25/15 12:51:53 PM
#11551   My wife loves her Pump as it made kugel 05/25/15 12:32:41 PM